Congenital Platelets Abnormality clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 21 years and up
This study will measure primary hemostatic ability using the T-TAS 01 System with PL chip, with a comparison to clinical truth.
San Francisco, California and other locations